Olsson H - Search Results

1

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.

Bratt O, Borg A, Kristoffersson U, Lundgren R, Zhang QX, Olsson H. Bratt O, et al. Among authors: olsson h. Br J Cancer. 1999 Oct;81(4):672-6. doi: 10.1038/sj.bjc.6690746. Br J Cancer. 1999. PMID: 10574254 Free PMC article.

2

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Borg A, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Olsson H, Killander D, McGurie WL. Borg A, et al. Among authors: olsson h. Br J Cancer. 1991 Jan;63(1):136-42. doi: 10.1038/bjc.1991.28. Br J Cancer. 1991. PMID: 1989653 Free PMC article.

3

The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study.

Bratt O, Kristoffersson U, Lundgren R, Olsson H. Bratt O, et al. Among authors: olsson h. Eur J Cancer. 1997 Nov;33(13):2237-40. doi: 10.1016/s0959-8049(97)00320-1. Eur J Cancer. 1997. PMID: 9470812

4

BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease.

Haraldsson K, Loman N, Zhang QX, Johannsson O, Olsson H, Borg A. Haraldsson K, et al. Among authors: olsson h. Cancer Res. 1998 Apr 1;58(7):1367-71. Cancer Res. 1998. PMID: 9537231

5

Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor.

Bratt O, Kristoffersson U, Olsson H, Lundgren R. Bratt O, et al. Among authors: olsson h. Eur Urol. 1998;34(1):19-24. doi: 10.1159/000019672. Eur Urol. 1998. PMID: 9676409

6

Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study.

Bratt O, Kristoffersson U, Lundgren R, Olsson H. Bratt O, et al. Among authors: olsson h. Eur J Cancer. 1999 Feb;35(2):272-7. doi: 10.1016/s0959-8049(98)00358-x. Eur J Cancer. 1999. PMID: 10448270

7

Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer.

Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H, Grönberg H. Bratt O, et al. Among authors: olsson h. Eur J Cancer. 2000 Jan;36(2):235-41. doi: 10.1016/s0959-8049(99)00272-5. Eur J Cancer. 2000. PMID: 10741283

8

Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.

Olsson H, Borg A, Fernö M, Möller TR, Ranstam J. Olsson H, et al. Cancer Detect Prev. 1991;15(4):265-71. Cancer Detect Prev. 1991. PMID: 1794133

9

Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.

Olsson H, Borg A, Fernö M, Ranstam J, Sigurdsson H. Olsson H, et al. J Natl Cancer Inst. 1991 Oct 16;83(20):1483-7. doi: 10.1093/jnci/83.20.1483. J Natl Cancer Inst. 1991. PMID: 1920494

10

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J. Sigurdsson H, et al. Among authors: olsson h. Br J Cancer. 1990 Nov;62(5):786-90. doi: 10.1038/bjc.1990.380. Br J Cancer. 1990. PMID: 2245171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

889 results

Search Page

Filters